小鼠肝细胞SMAC基因特异干扰载体的构建及慢病毒包装

吴凡; 易在凤; 田德英

doi:10.3969/j.issn.1001-5256.2014.05.015

小鼠肝细胞SMAC基因特异干扰载体的构建及慢病毒包装

DOI: 10.3969/j.issn.1001-5256.2014.05.015

1. 华中科技大学同济医学院附属同济医院感染科
2. 华中科技大学同济医学院附属协和医院中西医结合科

详细信息

中图分类号: R393
计量
- 文章访问数: 3021
- HTML全文浏览量: 15
- PDF下载量: 637
- 被引次数: 0
出版历程
- 出版日期: 2014-05-20

Construction of specific interference vector and lentiviral packaging for SMAC gene in mice

摘要

摘要:
目的构建并鉴定小鼠SMAC特异干扰载体,并进行慢病毒包装。方法针对小鼠SMAC基因设计并合成3对干扰序列siRNA1、siRNA2、siRNA3及一对阴性对照序列siRNAn,脂质体法转染小鼠肝细胞,Real time PCR法筛选出最佳干扰序列。依据该最佳干扰序列合成DNA oligo,连接GV115载体,获得重组干扰质粒,PCR鉴定阳性克隆并测序鉴定构建的正确性。将该重组干扰质粒与辅助质粒pHelper1.0和pHelper2.0共转染293T细胞,进行慢病毒包装,收集细胞上清并浓缩,梯度稀释法测定病毒滴度。多组间比较采用方差分析,进一步两两比较采用SNK-q检验。结果 3条siRNA对肝细胞SMAC mRNA均有不同程度的抑制作用,其中siRNA1的抑制效应最强,抑制效率达到70.3%。依siRNA1片段合成DNA oligo,并与慢病毒载体连接,测序显示其构建正确,梯度稀释法测定慢病毒滴度为6×108TU/ml。结论成功构建了小鼠SMAC基因特异干扰性的慢病毒,为研究SMAC基因在肝衰竭中的作用奠定基础。
- RNA干扰 /
- SMAC /
- 慢病毒属
Abstract:
Objective To construct and identify the specific interference vector for second mitochondria- derived activator of caspase ( SMAC) gene in mice and perform lentiviral packaging. Methods According to the SMAC gene sequences in mice, three small interfering RNAs ( siRNAs) ( siRNA1, siRNA2, and siRNA3) and one negative control sequence ( siRNAn) were designed and synthesized, and mouse hepatocytes were transfected with the above siRNAs using Lipofectamine 2000. The inhibitory effects of these siRNAs on SMAC mRNA expression were evaluated by real- time PCR, and the optimal siRNA was screened out accordingly. Oligo DNA was synthesized based on the optimal siRNA and then connected to GV115 vector to obtain recombinant interference plasmid. The candidate clones were identified by PCR and sequenced. The recombinant interference plasmid, as well as pHelper 1. 0 and pHelper 2. 0, was used to transfect 293T cells for lentivirus packaging. Then, cell supernatants were collected and concentrated, and the lentiviral titer was determined by gradient dilution. Comparison between groups was made by analysis of variance, and multiple comparisons were made by SNK- q test. Results The three siRNAs had different inhibitory effects on SMAC mRNA expression in hepatocytes; siRNA1 showed the strongest inhibitory effect, with an inhibition efficiency of 70. 3%. Based on siRNA1, the oligo DNA was successfully synthesized and correctly connected to the lentiviral vector, as proved by sequencing. The lentiviral titer was 6 × 108TU / ml, as determined by gradient dilution. Conclusion The recombinant lentivirus that inhibits SMAC expression in mice has been constructed successfully, laying the foundation for further studies on the role of SMAC gene in liver failure.
- RNA interference /
- SMAC /
- lentivirus

HTML全文

参考文献(14)

[1]YAO WM, CHEN Y, XIE CS, et al.Clinical study on Xuebijing combined with Thymosinα1 in treatment of chronic liver failure[J].J Clin Exp Med, 2012, 11 (6) :421-423. (in Chinese) 姚维敏, 陈焰, 谢春生, 等.血必净注射液联合胸腺肽α1治疗慢性肝衰竭的疗效观察[J].临床和实验医学杂志, 2012, 11 (6) :421-423.

[2]LUO M, CAO WK.Research progress on microbial modulators in treatment of severe hepatitis with endotoxemia[J].J Clin Hepatol, 2011, 27 (7) :775-778. (in Chinese) 罗明, 曹武奎.微生态调节剂治疗重型肝炎内毒素血症的研究进展[J].临床肝胆病杂志, 2011, 27 (7) :775-778.

[3]SUN HY, LIU L, LU JF, et al.Potent bivalent smac mimetics:effect of the linker on binding to inhibitor of apoptosis proteins (IAPs) and anticancer activity[J].J Med Chem, 2011, 54 (9) :3306-3318.

[4]CHEN M, ZHOU J, LI H, et al.Effects of endotoxin on liver smac apoptosis channel[J].J Huazhong U Sci-Med, 2008, 28 (6) :660-664.

[5]DU CY, FANG M, LI YC, et al.Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition[J].Cell, 2000, 102 (1) :33-42.

[6]EMEAGI PU, THIELEMANS K, BRECKPOT K.The role of SMAC mimetics in regulation of tumor cell death and immunity[J].Immunology, 2012, 1 (6) :965-967.

[7]GIAGKOUSIKLIDIS S, VOGLER M, WESTHOFF MA, et al.Sensitization for gamma-irradiation-induced apoptosis by second mitochondria-derived activator of caspase[J].Cancer Res, 2005, 65:10502-10513.

[8]KRAMER O, KLAISING S, NOLL T.Methods in mammalian cell line engineering:from random mutagenesis to sequence-specific approaches[J].Appl Microbiol Biot, 2010, 88 (2) :425-436.

[9]RAMACHANDRAN PV, IGNACIMUTHU S.RNA interference-a silent but an efficient therapeutic tool[J].Appl Microbiol Biot, 2013, 169 (6) :1774-1789.

[10]TAKAMURA K, TSUCHIDA K, MIYAKE H, et al.Activin and activin receptor expression changes in liver regeneration in rat[J].J Surg Res, 2005, 126 (1) :3-11.

[11]GRASSMANN R, JEANQ KT.The roles of microRNAs in mammalian virus infection[J].Biochim Biophys Acta, 2008, 1779 (11) :706-711.

[12]LEI M, JIAO HW, LIU T, et al.siRNA targeting mCD14 inhibits TNF-alpha, MIP-2, and IL-6 secretion and NO production from LPS-induced RAW264.7 cells[J].Appl Microbiol Biot, 2011, 92 (1) :115-124.

[13]RUBINSON DA, DILLON CP, KWIATKOWSKI AV, et al.A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference[J].Nature Genet, 2003, 33 (3) :401-406.

[14]ZHANG SM, XIE YM, HAO CQ, et al.Construction of the RNA interference vector of tissue inhibitor of matrix metalloproteinase-1gene and its inhibitory effects[J].J Clin Hepatol, 2012, 28 (2) :135-138. (in Chinese) 张素梅, 谢玉梅, 郝春秋, 等.基质金属蛋白酶抑制剂-1基因的RNA干扰载体构建及其抑制效应[J].临床肝胆病杂志, 2012, 28 (2) :135-138.

施引文献

资源附件(0)

访问统计